Advertisement

I Can’t Stop the Hemolysis!

  • Mark T. Friedman
  • Kamille A. West
  • Peyman Bizargity
  • Kyle Annen
  • Jeffrey S. Jhang
Chapter

Abstract

A 27-year-old woman with a history of sickle cell disease is admitted with pain crisis (pain in extremities and back) and possible sepsis. The patient, who has a history of anti-Fya and anti-S alloantibodies, has had several admissions to the hospital for pain crisis over the past 5 years. She was transfused two units of red blood cells (RBCs) 1 year ago and received RBC exchange transfusion (six units) for acute chest syndrome 2 years ago; all RBCs were matched by extended phenotype (C-, E-, K-negative) as per the blood bank’s policy for sickle cell patients. A type and screen sample (ethylenediaminetetraacetic acid, EDTA anticoagulant) is submitted to the blood bank.

Keywords

Anti-Fya antibody Anti-S antibody Duffy blood group Evanescence Hyperhemolysis syndrome MNS blood group S antigen 

References

  1. 1.
    Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37(4):382–92.CrossRefGoogle Scholar
  2. 2.
    Win N, Sinha S, Lee E, Mills W. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Transfus Med Rev. 2010;24(1):64–7.CrossRefGoogle Scholar
  3. 3.
    Gupta S, Fenves A, Nance ST, Sykes DB, Dzik WS. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Transfusion. 2015;55(3):623–8.CrossRefGoogle Scholar
  4. 4.
    Bachmeyer C, Maury J, Parrot A, Bachir D, Stankovic K, Girot R. Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol. 2010;85(1):91–2.PubMedGoogle Scholar
  5. 5.
    Uhlmann EJ, Shenoy S, Goodnough L. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion. Transfusion. 2013;54:384–8.PubMedGoogle Scholar
  6. 6.
    Gouveia ME, Soares NB, Santoro MS, de Azevedo FCM. Hyperhemolysis syndrome in a patient with sickle cell anemia: case report. Rev Bras Hematol Hemoter. 2015;37(4):266–8.CrossRefGoogle Scholar
  7. 7.
    Eberly LA, Osman D, Collins NP. Hyperhemolysis syndrome without underlying hematologic disease. Case Rep Hematol. 2015;2015:180526, 3 p.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Mark T. Friedman
    • 1
  • Kamille A. West
    • 2
  • Peyman Bizargity
    • 3
  • Kyle Annen
    • 4
  • Jeffrey S. Jhang
    • 1
  1. 1.Icahn School of MedicineMount Sinai Health SystemNew YorkUSA
  2. 2.Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesdaUSA
  3. 3.Department of Molecular & Human GeneticsBaylor College of MedicineHoustonUSA
  4. 4.Department of PathologyChildren’s Hospital ColoradoAuroraUSA

Personalised recommendations